|
Preliminary results for the year ended 31 December 2025
|
|
|
|
Jefferies London Healthcare conference presentation 2025
|
|
|
|
Interim results for the six months ended 30 June 2025 - 23 September 2025
|
|
|
|
OXB interim results presentation 2025 - 23 September 2025
|
|
|
|
Oxford Biomedica PLC interim results for the six months ended 30 June 2025 - 23 September 2025
|
|
|
|
Preliminary results for the year ended 31 December 2024 - 9th April 2025
|
|
|
|
Jefferies London Healthcare conference presentation 2024 - 19 November 2024
|
|
|
|
Interim results for the six months ended in 30 June 2024 - 23 September 2024
|
|
|
|
Preliminary results for the year ended 31 December 2023 - 29 April 2024
|
|
|
|
42nd Annual J.P. Morgan Healthcare conference presentation - 10 January 2024
|
|
|
|
Oxford Biomedica 2023 interim results - 21 September 2023
|
|
|
|
Preliminary results for the year ended 31 December 2022 - 25 April 2023
|
|
|
|
41st Annual J.P. Morgan Healthcare conference presentation - 11 January 2023
|
|
|
|
Oxford Biomedica corporate presentation November 2022 - 30 November 2022
|
|
|
|
Interim results for the six months ended 30 June 2022 - 15 September 2022
|
|
|
|
Oxford Biomedica corporate presentation August 2022 - 29 August 2022
|
|
|
|
AGM 2022 voting results and presentation - 30 May 2022
|
|
|
|
Oxford Biomedica corporate presentation March 2022 - 23 February 2022
|
|
|
|
Oxford Biomedica and Homology agreement: Analyst presentation January 2022 - 28 January 2022
|
|
|
|
Interim results for the six months ended 30 June 2021 - 22 September 2021
|
|
|
|
Preliminary results for the year ended 31 December 2020 - 15 April 2021
|
|
|
|
Interim results for the six months ended 30 June 2020 - 17 September 2020
|
|
|
|
Preliminary results for the year ended 31 December 2019 - 6 May 2020
|
|
|
|
Interim results for the six months ended 30 June 2019 - 4 September 2019
|
|
|
|
Preliminary results for the year ended 31 December 2018 - 14 March 2019
|
|
|
|
Analyst Presentation: Interim results for the six months ended 30 June 2018
|
|
|
|
Analyst Presentation: Oxford BioMedica and Axovant licence agreement - 6 June 2018
|
|
|
|
Preliminary results for the year ended 31 December 2017 - 15 March 2018
|
|
|
|
Analyst Presentation: Oxford BioMedica and Bioverativ Collaboration - 15 February 2018
|
|
|
|
Jefferies Presentation - 15 November 2017
|
|
|
|
Analyst Presentation: Interim results for the six months ended 30 June 2017 - 17 August 2017
|
|
|
|
Jefferies 2017 Global Healthcare Conference - 21 June 2017
|
|
|
|
Annual general meeting 2017 - 23 May 2017
|
|
|
|
Preliminary results for the year ended 31 December 2016 - 16 March 2017
|
|
|
|
BIO CEO & Investor Conference - 12 February 2017
|
|
|
|
Biotech and Money, Inv€$tival Showcase - 31 October 2016
|
|
|
|
Interim results for the six months ended 30 June 2016 - 5 September 2016
|
|
|
|
Jefferies 2016 Healthcare Conference - 30 May 2016
|
|
|
|
2015 Preliminary Results - 28 April 2016
|
|
|
|
Jefferies 2015 Global Healthcare Conference - 31 October 2015
|
|
|
|
Interim results for the six months ended 30 June 2015
|
|
|
|
JMP Securities Life Sciences Conference New York - June 2015
|
|
|
